Clinical Trials Logo

Clinical Trial Summary

The aim of this pilot cohort study is to investigate whether treatment with remote ischemic conditioning (RIC) has a beneficial effect on blood pressure as well as the immune system in pregnant women with newly diagnosed hypertension (> 140/58 mm Hg) or pre-eclampsia before gestational week 37+3.


Clinical Trial Description

Pre-eclampsia, which affects about 2 to 7% of pregnancies, is a major cause of maternal and perinatal morbidity and mortality. The onset of clinical symptoms (hypertension, proteinuria or end- organ dysfunction), are often seen in the last trimester of a pregnancy. The disease can have major consequences for both the child and the mother. Yet there are only very limited treatment options, where induced labour is the only healing treatment. Today, the treatment consists in limiting blood pressure increase with medical treatment, whereby the pregnancy most often can result in term delivery. Remote Ischaemic Conditioning (RIC) achieved by an automatic inflation of a blood pressure cuff to induce four 5-minute cycles of limb ischaemia and reperfusion, is a treatment that has been found to decrease the inflammatory response and lower blood pressure in states of myocardial infarction, chronic heart failure, and stroke. The treatment is virtually a cost-free non-pharmacological and non-invasive therapeutic strategy performed by the patient herself in her home. However, whether RIC actually can improve clinical outcomes in relation to lowering blood pressure and the inflammatory response in pregnant women with newly diagnosed hypertension is yet to be investigated. Aim and endpoint: The aim of this pilot cohort study is to investigate whether treatment with remote ischemic conditioning (RIC) has a beneficial effect on blood pressure as well as the immune system in pregnant women with newly diagnosed hypertension (> 140/58mm Hg) or pre-eclampsia before gestational week 37+3. Primary end-point • Median arterial blood pressure after 6 days of treatment Secondary end-point • Changes in the inflammatory response Design and method: In a pilot cohort study at Aarhus University Hospital, Regional Hospital Randers and Region Hospital Herning 20 pregnant women with signs of gestational hypertension or pre-eclampsia (systolic blood pressure above 140 and / or diastolic blood pressure over 85; +/- proteinuria, +/- clinical signs or subjective symptoms and signs) are to be enrolled. The study flowchart: Newly hospital referred women with signs of gestational hypertension or pre-eclampsia will be asked to participate. Informed consent will be obtained and blood pressure, blood samples, and weight will be measured. - Day 1: resting day at home - blood pressure measuring - Day 2-7: Morning: Blood pressure measuring and RIC treatment. Evening: blood pressure measuring - Day 7: In hospital: Blood samples and weight will be measured. Pros and cons: In relation to the inflation of the blood pressure cuff temporary moderate pains in the treated arm might occur. Otherwise, the RIC is without side effects. Two extra blood samples of app. 50 ml each will be drawn, with a small risk of local infection exist. The usefulness of the study The study is designed as a small pilot study. In which the set up will be tested and the effects on blood pressure and the inflammatory response in a relative small size will be explored. A larger randomised study will follow if the results show a positive trend. Positive as well as negative and inconclusive results will be widely disseminated through national and international scientific journals and conferences. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03323762
Study type Interventional
Source University of Aarhus
Contact
Status Completed
Phase N/A
Start date October 24, 2017
Completion date August 28, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06445543 - Nutrition Optimization and Community Upliftment for Postpartum Recovery: Intervention to Support Healing After Hypertensive Disorders of Pregnancy N/A
Completed NCT02384226 - User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
Completed NCT02148965 - Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial N/A
Completed NCT03215173 - Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease N/A
Recruiting NCT04604535 - The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy N/A
Recruiting NCT02920593 - A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Phase 4
Recruiting NCT04877119 - sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) Study
Recruiting NCT05773677 - Diet in Twin Pregnancy: the Wellness of Mother and Babies. N/A
Completed NCT04119232 - Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy N/A
Completed NCT05595629 - App-based Remote Blood Pressure Monitoring N/A
Completed NCT05542654 - The Effect of Foot Massage on Blood Pressure and Anxiety Levels in Pregnants With Hypertension N/A
Recruiting NCT03298802 - Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide Phase 3
Completed NCT03922087 - No-worry Baby Project
Recruiting NCT06069102 - Optimal Blood Pressure Treatment Thresholds Postpartum Phase 4
Recruiting NCT05888467 - Physical Activity and Cardiovascular Profile of Pre-conceptional Women at Risk for GHD N/A
Recruiting NCT06281665 - Treatment With Aspirin After Preeclampsia: TAP Trial Phase 4
Not yet recruiting NCT06320054 - Preventing Obstetric Complications With Dietary Intervention N/A
Not yet recruiting NCT06123377 - Angiogenic Factors in the Conservative Management of Gestational Hypertension N/A
Completed NCT05124327 - Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy N/A
Recruiting NCT06416995 - Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes